# US 2024/0252408 A1 · Deodorant compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0252408 A1
- Document ID: US20240252408A1
- Status: Published application
- Kind: A1
- Application number: 18/294,373
- Filed: 2022-07-26
- Published: 2024-08-01
- Earliest claimed: 2021-08-04
- Assignees: Conopco, Inc., d/b/a UNILEVER
- Applicants: Conopco, Inc., d/b/a UNILEVER
- Inventors: Sophie Louise Hollmerus; Joy Rachel McWalter; Alan Philip Rowland; Ophelie Marie-Pierre Cecile Torres; Iain Andrew Weddell
- Web page: https://patentgrep.com/patent/US20240252408A1

## CPC

- A61K 8/361: {Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof}
- A61K 8/046: {Aerosols; Foams}
- A61K 8/27: Zinc; Compounds thereof
- A61K 8/34: Alcohols
- A61Q 15/00: Anti-perspirants or body deodorants (deodorisation of air A61L9/00)
- A61K 2800/31: Anhydrous
- A61K 2800/49: Solubiliser, Solubilising system
- A61K 2800/58: Metal complex; Coordination compounds
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

A deodorant composition which is an ethanolic solution comprising a zinc dicarboxylate salt of a fatty acid having from 6 to 14 carbon atoms and a crystallisation inhibitor which prevents or reduces crystal formation from said solution.

## Claims

### Claim 1

A deodorant composition comprising:
an ethanolic solution comprising:
a zinc dicarboxylate salt of a fatty acid comprising from 6 to 14 carbon atoms; and
a crystallisation inhibitor which prevents or reduces crystal formation from said solution,
wherein the crystallisation inhibitor is a branched chain fatty acid comprising from 8 to 22 carbon atoms present.

### Claim 2 (depends on 1)

A deodorant composition according to claim 1, comprising less than 0.25% by weight of free water, based upon the weight of the composition excluding any volatile propellant that may be present therein.

### Claim 3 (depends on 1)

A deodorant composition according to claim 1, wherein the crystallisation inhibitor passes a test whereby a solution of zinc neodecanoate (2% by weight) is made in ethanol having a water content of less than 0.1% by weight, the solution is subsequently diluted 100× with the same ethanol used to form the initial solution, and the crystallisation inhibitor passes the test by showing no crystal formation in the diluted solution after a period of at least 12 hours.

### Claim 4

A deodorant composition according to any one of the preceding claims, wherein the crystallisation inhibitor is selected from the group consisting of 2,2-di-(n-propyl)acetic acid, 2,4-dimethyl-2-pentenoic acid, neodecanoic acid, 2-butyloctanoic acid and isostearic acid.

### Claim 5 (depends on 4)

A deodorant composition according to claim 4, wherein the crystallisation inhibitor is an α-branched chain fatty acid.

### Claim 6 (depends on 5)

A deodorant composition according to claim 5, wherein the crystallisation inhibitor has three alkyl substituents at the α-carbon.

### Claim 7 (depends on 6)

A deodorant composition according to claim 6, wherein the crystallisation inhibitor is neodecanoic acid.

### Claim 8 (depends on 1)

A deodorant composition according to claim 1, wherein the weight ratio crystallisation inhibitor to the zinc dicarboxylate salt is from 1:33 to 1:1.

### Claim 9 (depends on 1)

A deodorant composition according to claim 1 in the form of an aerosol composition.

### Claim 10 (depends on 9)

A deodorant composition according to claim 9 comprising a volatile propellant.

### Claim 11 (depends on 1)

A deodorant composition according to claim 1, wherein the ethanolic solution is homogeneous.

### Claim 12 (depends on 1)

A deodorant composition according to claim 1, wherein the zinc dicarboxylate salt is zinc neodecanoate.

### Claim 13 (depends on 1)

A non-therapeutic method for reducing body odour comprising the topical application of a deodorant composition according to claim 1.

### Claim 14 (depends on 1)

The non-therapeutic use of a composition according to claim 1 for reducing body odour on the surface of the human body.
